Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technetium [99mTc]-H7ND for Peritoneal Metastasis Diagnosis
NCT07107633Phase 2Recruiting
- Sponsor
- Pharmadax Genesis
- Start
- Mar 2025
- Primary completion
- Sep 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of technetium Tc 99m H7ND in peritoneal metastasis (PM), sponsored by Pharmadax Genesis. Started Mar 2025; status: recruiting.
02
Drugs
technetium Tc 99m H7ND
03
Conditions
peritoneal metastasis (PM)
Beyond the preview
Go deeper on NCT07107633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07107633.